5-aza-2'-deoxycytidine-5'-triphosphate has been researched along with African Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apa, AG; Arruda, VO; de Rezende, LM; Klumb, CE; Mazzoccoli, L; Reis, FR; Robaina, MC | 1 |
1 other study(ies) available for 5-aza-2'-deoxycytidine-5'-triphosphate and African Lymphoma
Article | Year |
---|---|
Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
Topics: Adolescent; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p16; Cytidine Triphosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Promoter Regions, Genetic; RNA, Messenger | 2015 |